|
|
Science Sparks @ ACTREC
|
2nd December 2024 |
Vol. No. 13 ; Issue No.658 |
|
Publications
|
1. Shinghal A, Pradhan S, Chopra S, Kapoor AR, Gupta A, Mittal P, Saini V, Jain J, Sanju S, Kapoor A, Giridhar P, Pujari L, Chowdhury Z, Gupta S (2024). Study protocol of Elective Para-aortic and pelvic versus Pelvic only Irradiation in pelvic node positive Cervical cancer: a multicentric open labelled phase III randomised controlled trial (EPIC Study). BMJ Open.14(11): .e08822
2. Noronha V, Menon N, Patil VM, Shah M, Joshi A, Shah S, Nawale K, Surve R, Bafna G, Jogdhankar S, Shelar P, Shetake A, Singh A, Salian S, Jadhav P, Shah H, Mer N, Vohra A, Majumdar S, Banavali S, Badwe R, Prabhash K (2024). Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial. British Journal of Cancer.
3. Gadewal N, Patidar D, Natu A, Gupta S, Bastikar V (2024). In silico screening of phytochemicals against chromatin modifier, SETD7 for remodeling of the immunosuppressive tumor microenvironment in renal cancer. Molecular Diversity.
4. Piñeros M, Vignat J, Colombet M, Laversanne M, Ferreccio C, Heise K, Mhatre S, Koshiol J, Bray F (2024). Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us? International Journal of Cancer.
|
|
|
Interesting Reads
|
Ren YF, Ma Q, Zeng X, Huang CX, Ren JL, Li F, Tong JJ, He JW, Zhong Y, Tan SY, Jiang H, Zhang LF, Lai HZ, Xiao P, Zhuang X, Wu P, You LT, Shi W, Fu X, Zheng C, You FM (2024). Single-cell RNA sequencing reveals immune microenvironment niche transitions during the invasive and metastatic processes of ground-glass nodules and part-solid nodules in lung adenocarcinoma. Molecular Cancer. 23(1):263.
|
|
Video of the Week
|
|
Chemotherapy-induced Cachexia and Model-informed Dosing to Preserve Lean Mass in Cancer Treatment |
|
|
|
|
|
|
Do You Know?
In 1958, scientist developed 5-fluorouracil (5-FU), a chemotherapy drug used to treat many cancers. It is a first-line treatment for colon cancer.
|
|
|
Cancer News
|
|
Glioblastoma treatment shows promise in mouse study
|
MedicalXpress, 28/11/2024
|
To investigate gliocidin's mechanism of action, researchers performed a genome-wide CRISPR–Cas9 knockout screen to identify genes that influence gliocidin's effectiveness against glioblastoma cells...
|
|
|
|
|
|
|
Bone marrow progenitor-like cells against leukemia cure.
|
Nature Cancer, 25/11/2024
|
Relapse in T cell acute lymphoblastic leukemia (T-ALL) constitutes a challenge. A subclonal population of bone marrow progenitor-like cells present in all T-ALL genetic or immunophenotypic subtypes is now shown to confer chemoresistance and poor prognosis, and to be targetable with anti-apoptotic agents...
|
|
|
|
|
|
2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|